EVEREST MEDICINES Trademark

Trademark Overview


On Thursday, February 22, 2024, a trademark application was filed for EVEREST MEDICINES with the United States Patent and Trademark Office. The USPTO has given the EVEREST MEDICINES trademark a serial number of 98977528. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Tuesday, February 24, 2026. This trademark is owned by Everest Medicines (Singapore) Pte. Ltd.. The EVEREST MEDICINES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical drugs, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for health care, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, de...
everest medicines

General Information


Serial Number98977528
Word MarkEVEREST MEDICINES
Filing DateThursday, February 22, 2024
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateTuesday, February 24, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements


Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical drugs, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for health care, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal.
NOT AVAILABLEMEDICINES

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 22, 2024
Primary Code005
First Use Anywhere DateThursday, February 20, 2025
First Use In Commerce DateThursday, February 20, 2025

Trademark Owner History


Party NameEverest Medicines (Singapore) Pte. Ltd.
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressSingapore 049712
SG

Party NameEverest Medicines (Singapore) Pte. Ltd.
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressSingapore 049712
SG

Trademark Events


Event DateEvent Description
Thursday, February 22, 2024NEW APPLICATION ENTERED
Friday, June 28, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 11, 2024ASSIGNED TO EXAMINER
Wednesday, September 11, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 11, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 8, 2025SOU TEAS EXTENSION RECEIVED
Friday, August 8, 2025TEAS STATEMENT OF USE RECEIVED
Friday, February 13, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 8, 2025TEAS REQUEST TO DIVIDE RECEIVED
Friday, August 8, 2025DIVISIONAL REQUEST RECEIVED
Tuesday, February 24, 2026DIVISIONAL PROCESSING COMPLETE
Friday, August 8, 2025USE AMENDMENT FILED
Tuesday, February 24, 2026STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 24, 2026SU - NON-FINAL ACTION - WRITTEN
Tuesday, February 24, 2026NON-FINAL ACTION E-MAILED
Tuesday, February 24, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED